immunohistostaining
immunohistopathology
histoantigen
immunohistomorphology
immunosorbance
immunocytohistochemistry
muromonab
antihistone
intrabody
antimonoclonal
antipolyvalent
antigenically
recognition
affinity
amlitelimab
bivatuzumab
glembatumumab
reagin
antiantibody
brolucizumab
abagovomab
tislelizumab
sintilimab
solitomab
ravulizumab
allotope
ziltivekimab
pidilizumab
retifanlimab
vanucizumab
zenocutuzumab
gevokizumab
toripalimab
pozelimab
antiidiotypic
dinutuximab
olaratumab
antisynthetase
immunohistocompatibility
sasanlimab
intetumumab
immunoprecipitant
chromobody
histocompatibility antigen
active immunity
tucotuzumab
elotuzumab
polytypic
sonepcizumab
cytotoxic reaction
cergutuzumab
immunopanning
autoaggression
histoimmunopathological
-mab
antigenomic
passive immunity
immunosynaptic
tisotumab
monoantibody
immunodeposit
paratope
bispecific
histoimmunochemistry
immunoconformational
immunodeposition
immunofluorohistochemistry
immunohistology
atezolizumab
immunoreactively
immunoabsorbent
alloantibody
heterophile
polyantibody
immunohistochemical
polyclonal
idiotope
conglutination
immunohistofluorescence
immunospecies
immunobinding
heterophilic
immunoreactant
immunoconjugation
immunodefensive
histoimmunochemical
immunocytology
Ab
immunoprobe
precipitin
immunodepletion
pathoantigen
immunocomplexemia
immunocytogenetic
anticorrelate
coimmunoprecipitation
hyperimmunization
immunoenrichment
agglutin